News and Insights from Our Multidisciplinary Team of Experts
AACR’s Annual Meeting brings us the latest and best in cancer science and medicine from institutions all over the world. This year’s meeting, held earlier this month in Chicago, did not disappoint. A few of our key takeaways included: The “omics” approach have given...
It is no secret that drug developers are under increasing pressure to discover new targeted therapies to meet high unmet medical needs, and to design clinical trials that will minimize the risk of failure to gain commercial approval. As research on diseases like...
New technology designed to speed dystrophin measurement while ensuring consistency Automation of dystrophin measurement will aid development of Sarepta’s Duchenne muscular dystrophy candidates Cambridge, Mass. - Aug 20, 2014 - Sarepta Therapeutics, Inc, a developer of...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
PUBLICATIONS/POSTERS
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
EVENTS
(Recorded live on Tuesday, July 14, 2020) Biomarkers are important tools for successful biopharmaceutical-targeted drug development and regulatory approval. Biomarkers can be diagnostic and/or prognostic, indicative of precision drug targeting. As such, biomarkers are...
(Recorded live on Thursday, April 16, 2020) Image analysis of histological tissue sections is a fast-growing field that is becoming widely accepted as a research tool for scientists and pathologists, providing quantitative, reproducible data in lieu of varying manual...
Flagship was a virtual exhibitor this year during the AACR Virtual Meeting II. Our scientists, led by Chuck Caldwell, shared a new poster during the virtual event.